Literature DB >> 7558767

Pavia memory project: study design and first results.

V Cosi1, A Citterio, M T Ratti, A Romani.   

Abstract

This paper describes the design and first results of the cross-sectional phase of a study on memory impairment in elderly subjects (Pavia Memory Project). The target population consisted of the 1,046 subjects born in 1925 and currently living in Pavia. Four hundred and thirty-six subjects (plus 287 interviewed at home) participated in the first stage, which consisted of a semi-structured anamnestic interview. The 400 interviewed subjects with none of the exclusion criteria participated in the second stage, which consisted of a memory test battery, a standardized neurological examination and screening procedures for depression (GDS) and dementia (MMSE). On the basis of the memory scores, three groups were defined: memory impairment (MI: 8.8%), mild memory impairment (MMI: 39.8%); normal (N: 51.3%). There were more failures on the visuo-spatial memory tests. Depression was equally distributed in the N and MI groups (about 15%), but was more frequent in the MMI group (27%). Abnormal neurological signs were largely independent of memory performance. Two cohorts (of MI and N subjects) underwent neuropsychological and instrumental (CT-scan, EEG, ERPs, eye movements) assessment, which will be regularly repeated in the longitudinal phase.

Entities:  

Mesh:

Year:  1995        PMID: 7558767     DOI: 10.1007/bf02282980

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  14 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Sex differences in spatial memory: a reanalysis of block tapping long-term memory according to the short-term memory level.

Authors:  E Capitani; M Laiacona; E Ciceri
Journal:  Ital J Neurol Sci       Date:  1991-10

3.  The electroencephalogram in Alzheimer-type dementia. A sequential study correlating the electroencephalogram with psychometric and quantitative pathologic data.

Authors:  A Rae-Grant; W Blume; C Lau; V C Hachinski; M Fisman; H Merskey
Journal:  Arch Neurol       Date:  1987-01

4.  Brain parenchymal density measurements by CT in demented subjects and normal controls.

Authors:  M Gado; W L Danziger; D Chi; C P Hughes; L A Coben
Journal:  Radiology       Date:  1983-06       Impact factor: 11.105

5.  Neurologic signs in senescence.

Authors:  L R Jenkyn; A G Reeves; T Warren; R K Whiting; R J Clayton; W W Moore; A Rizzo; I M Tuzun; J C Bonnett; B W Culpepper
Journal:  Arch Neurol       Date:  1985-12

6.  P300 assessment of early Alzheimer's disease.

Authors:  J Polich; C Ladish; F E Bloom
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1990 May-Jun

7.  Saccadic eye movement dysfunction in Alzheimer's disease.

Authors:  W A Fletcher; J A Sharpe
Journal:  Ann Neurol       Date:  1986-10       Impact factor: 10.422

8.  The assessment of changes in brain volume using combined linear measurements. A CT-scan study.

Authors:  J M Gomori; I Steiner; E Melamed; G Cooper
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

9.  Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children.

Authors:  A Orsini; D Grossi; E Capitani; M Laiacona; C Papagno; G Vallar
Journal:  Ital J Neurol Sci       Date:  1987-12

10.  Use of computerized CT analysis to discriminate between Alzheimer patients and normal control subjects.

Authors:  T Sandor; M Albert; J Stafford; S Harpley
Journal:  AJNR Am J Neuroradiol       Date:  1988 Nov-Dec       Impact factor: 3.825

View more
  1 in total

Review 1.  Are cognitively impaired individuals adequately represented in community surveys? Recruitment challenges and strategies to facilitate participation in community surveys of older adults. A review.

Authors:  S G Riedel-Heller; A Busse; M C Angermeyer
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.